Logo image of 1GILD.MI

GILEAD SCIENCES INC (1GILD.MI) Stock Fundamental Analysis

Europe - BIT:1GILD - US3755581036 - Common Stock

105.88 EUR
+7.72 (+7.86%)
Last: 10/20/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, 1GILD scores 6 out of 10 in our fundamental rating. 1GILD was compared to 74 industry peers in the Biotechnology industry. 1GILD has an excellent profitability rating, but there are some minor concerns on its financial health. 1GILD may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make 1GILD suitable for value investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

1GILD had positive earnings in the past year.
In the past year 1GILD had a positive cash flow from operations.
1GILD had positive earnings in each of the past 5 years.
Each year in the past 5 years 1GILD had a positive operating cash flow.
1GILD.MI Yearly Net Income VS EBIT VS OCF VS FCF1GILD.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

1GILD has a better Return On Assets (13.86%) than 85.14% of its industry peers.
1GILD has a better Return On Equity (37.80%) than 95.95% of its industry peers.
Looking at the Return On Invested Capital, with a value of 18.54%, 1GILD belongs to the top of the industry, outperforming 91.89% of the companies in the same industry.
1GILD had an Average Return On Invested Capital over the past 3 years of 16.22%. This is above the industry average of 14.02%.
The last Return On Invested Capital (18.54%) for 1GILD is above the 3 year average (16.22%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROIC 18.54%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
1GILD.MI Yearly ROA, ROE, ROIC1GILD.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

1GILD's Profit Margin of 27.88% is amongst the best of the industry. 1GILD outperforms 87.84% of its industry peers.
1GILD's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 38.96%, 1GILD belongs to the top of the industry, outperforming 93.24% of the companies in the same industry.
In the last couple of years the Operating Margin of 1GILD has grown nicely.
With a decent Gross Margin value of 78.72%, 1GILD is doing good in the industry, outperforming 68.92% of the companies in the same industry.
In the last couple of years the Gross Margin of 1GILD has remained more or less at the same level.
Industry RankSector Rank
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
1GILD.MI Yearly Profit, Operating, Gross Margins1GILD.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

1GILD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, 1GILD has about the same amount of shares outstanding.
The number of shares outstanding for 1GILD has been reduced compared to 5 years ago.
Compared to 1 year ago, 1GILD has a worse debt to assets ratio.
1GILD.MI Yearly Shares Outstanding1GILD.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
1GILD.MI Yearly Total Debt VS Total Assets1GILD.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

1GILD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC2.31
WACC8.01%
1GILD.MI Yearly LT Debt VS Equity VS FCF1GILD.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

A Current Ratio of 1.53 indicates that 1GILD should not have too much problems paying its short term obligations.
1GILD has a Current ratio of 1.53. This is comparable to the rest of the industry: 1GILD outperforms 40.54% of its industry peers.
1GILD has a Quick Ratio of 1.17. This is a normal value and indicates that 1GILD is financially healthy and should not expect problems in meeting its short term obligations.
1GILD has a Quick ratio of 1.17. This is in the lower half of the industry: 1GILD underperforms 66.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.17
1GILD.MI Yearly Current Assets VS Current Liabilites1GILD.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

5

3. Growth

3.1 Past

1GILD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.88%, which is quite impressive.
The Earnings Per Share has been decreasing by -7.01% on average over the past years.
1GILD shows a small growth in Revenue. In the last year, the Revenue has grown by 2.78%.
1GILD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.08% yearly.
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%

3.2 Future

1GILD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.75% yearly.
1GILD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.34% yearly.
EPS Next Y77.74%
EPS Next 2Y37.95%
EPS Next 3Y27.38%
EPS Next 5Y19.75%
Revenue Next Year1.79%
Revenue Next 2Y2.77%
Revenue Next 3Y3.74%
Revenue Next 5Y4.34%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1GILD.MI Yearly Revenue VS Estimates1GILD.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
1GILD.MI Yearly EPS VS Estimates1GILD.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.93, the valuation of 1GILD can be described as correct.
Based on the Price/Earnings ratio, 1GILD is valued cheaper than 86.49% of the companies in the same industry.
1GILD is valuated rather cheaply when we compare the Price/Earnings ratio to 26.10, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 13.95, 1GILD is valued correctly.
Based on the Price/Forward Earnings ratio, 1GILD is valued cheaper than 89.19% of the companies in the same industry.
1GILD is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.52, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.93
Fwd PE 13.95
1GILD.MI Price Earnings VS Forward Price Earnings1GILD.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1GILD is valued cheaper than 86.49% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1GILD is valued cheaper than 87.84% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.94
EV/EBITDA 10.1
1GILD.MI Per share data1GILD.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

1GILD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1GILD has an outstanding profitability rating, which may justify a higher PE ratio.
1GILD's earnings are expected to grow with 27.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.19
PEG (5Y)N/A
EPS Next 2Y37.95%
EPS Next 3Y27.38%

6

5. Dividend

5.1 Amount

1GILD has a Yearly Dividend Yield of 2.67%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 10.16, 1GILD pays a better dividend. On top of this 1GILD pays more dividend than 93.24% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, 1GILD has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.67%

5.2 History

The dividend of 1GILD has a limited annual growth rate of 4.45%.
Dividend Growth(5Y)4.45%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

1GILD pays out 12.00% of its income as dividend. This is a sustainable payout ratio.
1GILD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP12%
EPS Next 2Y37.95%
EPS Next 3Y27.38%
1GILD.MI Yearly Income VS Free CF VS Dividend1GILD.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
1GILD.MI Dividend Payout.1GILD.MI Dividend Payout, showing the Payout Ratio.1GILD.MI Dividend Payout.PayoutRetained Earnings

GILEAD SCIENCES INC

BIT:1GILD (10/20/2025, 7:00:00 PM)

105.88

+7.72 (+7.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-09 2026-02-09/amc
Inst Owners90.76%
Inst Owner ChangeN/A
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap131.38B
Revenue(TTM)29.09B
Net Income(TTM)8.11B
Analysts81.11
Price Target112.24 (6.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.67%
Yearly Dividend2.72
Dividend Growth(5Y)4.45%
DP12%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)2.79%
PT rev (3m)7.28%
EPS NQ rev (1m)-2.63%
EPS NQ rev (3m)2.11%
EPS NY rev (1m)-0.8%
EPS NY rev (3m)0.9%
Revenue NQ rev (1m)0.56%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE 14.93
Fwd PE 13.95
P/S 5.22
P/FCF 15.94
P/OCF 15.7
P/B 7.07
P/tB N/A
EV/EBITDA 10.1
EPS(TTM)7.09
EY6.7%
EPS(NY)7.59
Fwd EY7.17%
FCF(TTM)6.64
FCFY6.27%
OCF(TTM)6.74
OCFY6.37%
SpS20.29
BVpS14.97
TBVpS-3.37
PEG (NY)0.19
PEG (5Y)N/A
Graham Number48.86
Profitability
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROCE 24.51%
ROIC 18.54%
ROICexc 23.24%
ROICexgc 80.87%
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
FCFM 32.73%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
ROICexc(3y)19.38%
ROICexc(5y)17.72%
ROICexgc(3y)93.83%
ROICexgc(5y)93.24%
ROCE(3y)21.45%
ROCE(5y)19.94%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y15.06%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.39%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 68.56%
Profit Quality 117.39%
Current Ratio 1.53
Quick Ratio 1.17
Altman-Z N/A
F-Score7
WACC8.01%
ROIC/WACC2.31
Cap/Depr(3y)25.08%
Cap/Depr(5y)29.48%
Cap/Sales(3y)2.21%
Cap/Sales(5y)2.28%
Profit Quality(3y)819.86%
Profit Quality(5y)1749.07%
High Growth Momentum
Growth
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
EPS Next Y77.74%
EPS Next 2Y37.95%
EPS Next 3Y27.38%
EPS Next 5Y19.75%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%
Revenue Next Year1.79%
Revenue Next 2Y2.77%
Revenue Next 3Y3.74%
Revenue Next 5Y4.34%
EBIT growth 1Y4.49%
EBIT growth 3Y2.36%
EBIT growth 5Y12.88%
EBIT Next Year75.69%
EBIT Next 3Y25.29%
EBIT Next 5Y19.07%
FCF growth 1Y21.23%
FCF growth 3Y-1.57%
FCF growth 5Y4.37%
OCF growth 1Y15.03%
OCF growth 3Y-1.66%
OCF growth 5Y3.44%

GILEAD SCIENCES INC / 1GILD.MI FAQ

What is the ChartMill fundamental rating of GILEAD SCIENCES INC (1GILD.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1GILD.MI.


What is the valuation status of GILEAD SCIENCES INC (1GILD.MI) stock?

ChartMill assigns a valuation rating of 8 / 10 to GILEAD SCIENCES INC (1GILD.MI). This can be considered as Undervalued.


What is the profitability of 1GILD stock?

GILEAD SCIENCES INC (1GILD.MI) has a profitability rating of 8 / 10.


Can you provide the financial health for 1GILD stock?

The financial health rating of GILEAD SCIENCES INC (1GILD.MI) is 5 / 10.


How sustainable is the dividend of GILEAD SCIENCES INC (1GILD.MI) stock?

The dividend rating of GILEAD SCIENCES INC (1GILD.MI) is 5 / 10 and the dividend payout ratio is 12%.